Anna Rohlin

706 total citations
18 papers, 478 citations indexed

About

Anna Rohlin is a scholar working on Pathology and Forensic Medicine, Genetics and Molecular Biology. According to data from OpenAlex, Anna Rohlin has authored 18 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 9 papers in Genetics and 7 papers in Molecular Biology. Recurrent topics in Anna Rohlin's work include Genetic factors in colorectal cancer (10 papers), Cancer Genomics and Diagnostics (7 papers) and Genomics and Rare Diseases (6 papers). Anna Rohlin is often cited by papers focused on Genetic factors in colorectal cancer (10 papers), Cancer Genomics and Diagnostics (7 papers) and Genomics and Rare Diseases (6 papers). Anna Rohlin collaborates with scholars based in Sweden, Denmark and United Kingdom. Anna Rohlin's co-authors include Margareta Nordling, Jan Björk, Yvonne Engwall, Leif Wiklund, Mef Nilbert, Theofanis Zagoras, Ulf Lundstam, Göran Karlsson, Staffan Nilsson and Per Karlsson and has published in prestigious journals such as Oncogene, International Journal of Cancer and BMC Bioinformatics.

In The Last Decade

Anna Rohlin

18 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Rohlin Sweden 10 285 176 171 170 139 18 478
Joan Shaw United Kingdom 6 275 1.0× 218 1.2× 109 0.6× 178 1.0× 83 0.6× 9 476
Ian Chandler United Kingdom 12 236 0.8× 163 0.9× 85 0.5× 163 1.0× 76 0.5× 15 420
Capucine Delnatte France 9 136 0.5× 219 1.2× 78 0.5× 100 0.6× 144 1.0× 15 426
Nando Di Nicola Canada 8 348 1.2× 186 1.1× 154 0.9× 225 1.3× 108 0.8× 9 520
Isabel Spier Germany 13 307 1.1× 293 1.7× 145 0.8× 183 1.1× 221 1.6× 36 662
F. H. Menko Netherlands 8 250 0.9× 116 0.7× 131 0.8× 135 0.8× 137 1.0× 12 396
Emily Rayner Netherlands 6 166 0.6× 197 1.1× 176 1.0× 144 0.8× 48 0.3× 8 441
Patrícia Rocha Portugal 12 116 0.4× 179 1.0× 139 0.8× 141 0.8× 121 0.9× 21 369
Melissa D. Gordon United States 7 257 0.9× 221 1.3× 141 0.8× 117 0.7× 51 0.4× 10 427
Yvonne Engwall Sweden 7 271 1.0× 165 0.9× 95 0.6× 160 0.9× 161 1.2× 9 508

Countries citing papers authored by Anna Rohlin

Since Specialization
Citations

This map shows the geographic impact of Anna Rohlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Rohlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Rohlin more than expected).

Fields of papers citing papers by Anna Rohlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Rohlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Rohlin. The network helps show where Anna Rohlin may publish in the future.

Co-authorship network of co-authors of Anna Rohlin

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Rohlin. A scholar is included among the top collaborators of Anna Rohlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Rohlin. Anna Rohlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Svensson, Johanna, Maria Yhr, Sama I. Sayin, et al.. (2025). Comprehensive genetic variant analysis reveals combination of KRAS and LRP1B as a predictive biomarker of response to immunotherapy in patients with non-small cell lung cancer. Journal of Experimental & Clinical Cancer Research. 44(1). 75–75. 1 indexed citations
2.
Svensson, Johanna, Volkan I. Sayin, Anna Rohlin, et al.. (2025). High baseline PD-1+ CD8 T Cells and TIGIT+ CD8 T Cells in circulation associated with response to PD-1 blockade in patients with non-small cell lung cancer. Cancer Immunology Immunotherapy. 74(10). 309–309. 1 indexed citations
3.
Topa, Alexandra, Anna Rohlin, André Fehr, et al.. (2024). The value of genome-wide analysis in craniosynostosis. Frontiers in Genetics. 14. 1322462–1322462. 3 indexed citations
4.
Rohlin, Anna, Maria K. Magnusson, Levent M. Akyürek, et al.. (2023). Combinatory analysis of immune cell subsets and tumor-specific genetic variants predict clinical response to PD-1 blockade in patients with non-small cell lung cancer. Frontiers in Oncology. 12. 1073457–1073457. 3 indexed citations
5.
Rohlin, Anna, et al.. (2022). PΨFinder: a practical tool for the identification and visualization of novel pseudogenes in DNA sequencing data. BMC Bioinformatics. 23(1). 59–59. 1 indexed citations
6.
Topa, Alexandra, Anna Rohlin, Mattias K. Andersson, et al.. (2022). The outcome of targeted NGS screening in patients with syndromic forms of sagittal and pansynostosis - IL11RA is an emerging core-gene for pansynostosis. European Journal of Medical Genetics. 65(5). 104476–104476. 4 indexed citations
7.
Zagoras, Theofanis, Marie Stenmark Askmalm, Erik Björck, et al.. (2022). Merged testing for colorectal cancer syndromes and re‐evaluation of genetic variants improve diagnostic yield: Results from a nationwide prospective cohort. Genes Chromosomes and Cancer. 61(10). 585–591. 2 indexed citations
8.
Helgadóttir, Hafdís T., Jessada Thutkawkorapin, Anna Rohlin, et al.. (2021). Identification of known and novel familial cancer genes in Swedish colorectal cancer families. International Journal of Cancer. 149(3). 627–634. 2 indexed citations
9.
Hallqvist, Andreas, Anna Rohlin, & Sukanya Raghavan. (2020). Immune checkpoint blockade and biomarkers of clinical response in non–small cell lung cancer. Scandinavian Journal of Immunology. 92(6). e12980–e12980. 18 indexed citations
10.
Topa, Alexandra, Anna Rohlin, Mattias K. Andersson, et al.. (2019). NGS targeted screening of 100 Scandinavian patients with coronal synostosis. American Journal of Medical Genetics Part A. 182(2). 348–356. 13 indexed citations
11.
Nieminen, Taina T., Anna Rohlin, Ari Ristimäki, et al.. (2018). Biallelic germline nonsense variant of MLH3 underlies polyposis predisposition. Genetics in Medicine. 21(8). 1868–1873. 40 indexed citations
12.
Rohlin, Anna, Eva Rambech, Anders Kvist, et al.. (2016). Expanding the genotype–phenotype spectrum in hereditary colorectal cancer by gene panel testing. Familial Cancer. 16(2). 195–203. 45 indexed citations
13.
Lagerstedt‐Robinson, Kristina, Anna Rohlin, Beatrice Melin, et al.. (2016). Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population. Oncology Reports. 36(5). 2823–2835. 42 indexed citations
14.
Rohlin, Anna, Ulf Lundstam, Theofanis Zagoras, et al.. (2015). GREM1 and POLE variants in hereditary colorectal cancer syndromes. Genes Chromosomes and Cancer. 55(1). 95–106. 29 indexed citations
15.
Rohlin, Anna, Theofanis Zagoras, Staffan Nilsson, et al.. (2014). A mutation in POLE predisposing to a multi-tumour phenotype. International Journal of Oncology. 45(1). 77–81. 56 indexed citations
16.
Rohlin, Anna, Yvonne Engwall, Katarina E. Göransson, et al.. (2011). Inactivation of promoter 1B of APC causes partial gene silencing: evidence for a significant role of the promoter in regulation and causative of familial adenomatous polyposis. Oncogene. 30(50). 4977–4989. 44 indexed citations
17.
Rohlin, Anna, et al.. (2009). Parallel sequencing used in detection of mosaic mutations: Comparison with four diagnostic DNA screening techniques. Human Mutation. 30(6). 1012–1020. 138 indexed citations
18.
Kanter-Smoler, Gunilla, Anna Rohlin, Yvonne Engwall, et al.. (2008). Clinical characterization and the mutation spectrum in Swedish adenomatous polyposis families. BMC Medicine. 6(1). 10–10. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joan Shaw Breakdown of academic impact, for papers by Ian Chandler Breakdown of academic impact, for papers by Capucine Delnatte Breakdown of academic impact, for papers by Nando Di Nicola Breakdown of academic impact, for papers by Isabel Spier Breakdown of academic impact, for papers by F. H. Menko Breakdown of academic impact, for papers by Emily Rayner Breakdown of academic impact, for papers by Patrícia Rocha Breakdown of academic impact, for papers by Melissa D. Gordon Breakdown of academic impact, for papers by Yvonne Engwall
Rankless by CCL
2026